PCM
TVGN icon

Prelude Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Prelude Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-978
Closed -$489K – 1992
2022
Q2 		$489K Hold
978
– – 0.01% 823
2022
Q1 		$489K Buy
+978
New +$486K 0.01% 877

Other funds holding TVGN

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Prelude Capital Management's TVGN Position: Q3 2022 in Review

Prelude Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q3 2022, closing a stake of 978 shares — an estimated $489K sold.

Prelude Capital Management first reported a position in TVGN in Q1 2022 and held it in 2 quarters. The position peaked at $489K in Q2 2022. 62 funds tracked by Wall St. Rank hold TVGN as of Q3 2022.

  • Prelude Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Prelude Capital Management sold 978 Tevogen Inc. Common Stock shares in Q3 2022, an estimated $489K.
  • Prelude Capital Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Prelude Capital Management's Tevogen Inc. Common Stock position peaked at $489K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q3 2022.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.